C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2481300
The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus and/or venous thrombosis/pulmonary embolism, wherein the presence of an amino acid exchange at position 286 from Valine (Val) to Alanine (Ala) in the EDG5 protein is determined in a probe.
L'invention concerne un procédé permettant d'identifier une augmentation du risque des diabètes sucrés type II et/ou de thrombose veineuse/d'embolie pulmonaire, la présence d'un échange d'acides aminés en position 286 de la valine (Val) à l'Alanine dans la protéine EDG5 étant déterminée par une sonde.
Deleuze Jean-Francois
Jacobs Martina
Kostenis Evi
Kozian Detlef
Mace Sandrine
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Association of edg5 polymorphism v286a with type ii diabetes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Association of edg5 polymorphism v286a with type ii diabetes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Association of edg5 polymorphism v286a with type ii diabetes... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1566548